Eurofarma Laboratórios S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was BRL 8,006.28 million compared to BRL 7,067.83 million a year ago. Net income was BRL 934.51 million compared to BRL 957.52 million a year ago.

Basic earnings per share from continuing operations was BRL 0.9463 compared to BRL 1.1151 a year ago. Diluted earnings per share from continuing operations was BRL 0.9463 compared to BRL 1.1151 a year ago.